Influencia del tiempo de perfusión de pamidronato en la función renal de pacientes con mieloma múltiple

Reducing administration time for pamidronate from four to 2 h did not lead to significant variations in patients' renal function. This therapeutic practice can improve patients' quality of life by shortening their hospital stay without aggravating their renal function.